|
Volumn 53, Issue 7, 2005, Pages 1269-1270
|
Treatment persistency with rivastigmine and donepezil in a large state Medicaid program [8]
a,b c c b b |
Author keywords
[No Author keywords available]
|
Indexed keywords
CHOLINESTERASE INHIBITOR;
DONEPEZIL;
RIVASTIGMINE;
CARBAMIC ACID DERIVATIVE;
INDAN DERIVATIVE;
PIPERIDINE DERIVATIVE;
ALZHEIMER DISEASE;
DRUG EFFICACY;
DRUG TOLERABILITY;
HEALTH CARE;
HEALTH PROGRAM;
HUMAN;
LETTER;
MEDICAID;
TREATMENT OUTCOME;
AGED;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
MALE;
METHODOLOGY;
PATIENT COMPLIANCE;
RANDOMIZED CONTROLLED TRIAL;
AGED;
ALZHEIMER DISEASE;
CHOLINESTERASE INHIBITORS;
FEMALE;
HUMANS;
INDANS;
MALE;
PATIENT COMPLIANCE;
PHENYLCARBAMATES;
PIPERIDINES;
RESEARCH DESIGN;
|
EID: 24344477132
PISSN: 00028614
EISSN: 15325415
Source Type: Journal
DOI: 10.1111/j.1532-5415.2005.53384_9.x Document Type: Letter |
Times cited : (43)
|
References (5)
|